In individuals who are deficient in CYP2D6, coadministration of modafinil with substrates of CYP2D6 which have ancillary routes of elimination as a result of CYP2C19 (eg, tricyclic antidepressants and selective serotonin reuptake inhibitors) may bring about elevated circulating amounts of these medicines and demand dose adjustment (Robertson et al … Read More

This Article is Under Review… Read More